📜 MFN treatment is a unique principle enshrined in the TRIPS Agreement and represents a traditional principle originating in GATT, and not to be found in any other IP conventions. The principle has been broadly applied, given that a country that wishes to accede to the WTO must sign the TRIPS Agreement, one of the three pillars of the World Trade Organization (WTO). MFN treatment means that with regard to IP protection, any advantage, favor, privilege or immunity granted by a member to the nationals of any other country shall be accorded immediately and unconditionally to the nationals of all other member states.

🛈 https://www.wipo.int/edocs/pubdocs/en/wipo_pub_1056.pdf